CA2527178A1 — New long-acting drug combinations for the treatment of respiratory complaints
Assigned to Boehringer Ingelheim International GmbH · Expires 2004-12-09 · 21y expired
What this patent protects
The invention relates to novel medicament compositions based on a novel anticholinergic agent and a novel long-acting .beta.2-agonist. The invention also relates to the production and utilization of said compositions in the therapy of respiratory tract diseases.
USPTO Abstract
The invention relates to novel medicament compositions based on a novel anticholinergic agent and a novel long-acting .beta.2-agonist. The invention also relates to the production and utilization of said compositions in the therapy of respiratory tract diseases.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.